Mirum Pharmaceuticals Inc.
MIRM | NASDAQ
$92
+$0.17 (+0.19%)
At close: Sep 21, 2026, 4:00 PM ET
$91.71
-$0.29 (-0.32%)
Pre-market:
Sep 22, 2026, 6:14 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 521.31M | 336.89M | 186.37M | 77.06M | 19.14M | n/a |
Cost of Revenue | 100.58M | 81.64M | 47.04M | 12.37M | 1.9M | 623K |
Gross Profit | 420.73M | 255.25M | 139.34M | 64.69M | 17.24M | -623K |
Operating Income | -22.14M | -87.61M | -109.15M | -131.22M | -173.41M | -104.3M |
Interest Income | 12.73M | 13.79M | 13.74M | 3.86M | 366K | 1.56M |
Pretax Income | -21.43M | -86.91M | -162.42M | -142.07M | -83.95M | -103.26M |
Net Income | -23.36M | -87.94M | -163.42M | -135.67M | -83.99M | -103.27M |
Selling & General & Admin | 257.03M | 202.22M | 145.88M | 89.07M | 59.22M | 22.69M |
Research & Development | 186.18M | 140.63M | 102.61M | 106.84M | 131.43M | 81.61M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -623K |
Operating Expenses | 443.21M | 342.85M | 248.49M | 195.91M | 190.65M | 103.67M |
Interest Expense | 14.39M | 14.31M | 15.11M | 15.98M | 17.59M | 335K |
Selling & Marketing Expenses | n/a | 11.5M | 6.3M | n/a | 9.2M | n/a |
Cost & Expenses | 543.45M | 424.49M | 295.53M | 208.28M | 192.55M | 104.3M |
Income Tax Expense | 1.94M | 1.03M | 991K | -6.41M | 37K | 6K |
Shares Outstanding (Basic) | 50.2M | 47.52M | 40.89M | 33.84M | 30.32M | 25.25M |
Shares Outstanding (Diluted) | 50.2M | 47.52M | 40.89M | 33.98M | 30.32M | 25.25M |
EPS (Basic) | -0.47 | -1.85 | -4 | -4.01 | -2.77 | -4.09 |
EPS (Diluted) | -0.47 | -1.85 | -4 | -4.02 | -2.77 | -4.09 |
EBITDA | 17.21M | -48.97M | -136.49M | -122.85M | -65.39M | -102.31M |
EBIT | -7.04M | -72.6M | -147.32M | -126.09M | -66.36M | -102.93M |
Depreciation & Amortization | 24.24M | 23.63M | 10.83M | 3.24M | 975K | 623K |
Add to Watchlist
Select watchlists to add or remove MIRM